Tirzepatide Reconstitution Calculator
Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.
What amount do you need?
Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.
Syringe size:
Possible vial strengths:
Best Match
Good Match
Usable
Harder to Measure
Example Tirzepatide Titration Schedule
| Protocol Item | Guidance (As Listed) |
|---|---|
| Dose | 1–5 mg per dose |
| Frequency | 1× weekly |
| Cycle | 3-month cycles, with a minimum 1 month off |
| Extension | Cycles may be extended depending on response and goal |
Possible vial strengths:
What Is It?
Tirzepatide
Dual GLP-1 / GIP agonist used in metabolic research.
Bacteriostatic Water
Sterile water containing a bacteriostatic preservative, commonly used when preparing multi-use research vials.
How To Mix Tirzepatide
1
CleanUse alcohol swabs to clean the tops of both vials.
2
Draw BAC WaterDraw the selected amount of bacteriostatic water.
3
Inject SlowlyAdd the liquid slowly down the side of the vial.
4
Swirl GentlyDo not shake. Swirl gently until dissolved.
5
Store ProperlyStore as directed and protect from heat and light.
Best Practices & Common Mistakes
Best Practices
- Use sterile technique.
- Protect from light and heat.
- Store refrigerated when appropriate.
- Use clean syringe-unit math before measuring.
Common Mistakes
- Confusing milligrams with milliliters.
- Choosing an option with awkward decimal units.
- Using too little liquid for very small measurements.
- Shaking the vial aggressively.
Tirzepatide Storage & Handling
Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.
Frequently Asked Questions
Yes. Tirzepatide's elimination half-life is about 5 days. This allows once-weekly subcutaneous dosing. Your calculator's "Doses per vial" should be based on a weekly schedule, not daily.
Yes, but the schedule is key. The FDA-approved titration moves through 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg, with at least 4 weeks at each step. 2.5 mg is a starter dose, not a maintenance dose. Your calculator's output is correct for a single weekly dose; just remember the full schedule.
A common research mix is: 1 mL BAC water for a 5 mg vial → concentration 5 mg/mL. Then 2.5 mg = 0.5 mL (50 units) on a U-100 syringe, which is comfortable to draw. High concentrations (e.g., 1 mL for 10 mg = 10 mg/mL) make small doses hard to measure.
For research‑grade vials, after reconstitution with bacteriostatic water, the solution is stable at 2–8 °C for up to 1 week, and for longer storage it can be aliquoted and frozen at –20 °C for up to 12 months. Your calculator's "Doses per vial" count is a mathematical maximum; for extended use, freeze single‑use aliquots to avoid repeated freeze‑thaw cycles.
Not at all. The approved clinical dosing (2.5–15 mg) already accounts for this 80% bioavailability. The calculator should still produce the correct volume based on the entered mg. You do not need to adjust the mass upward.
Practical takeaway: If your real goal is weight or metabolic health, the most useful next step is discussing approved treatment options with a clinician rather than relying on an unapproved compound.
Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.